Charles Sawyers

Scientific Founder at Blueprint Medicines Corp.

Charles Sawyers

Charles Sawyers

Scientific Founder at Blueprint Medicines Corp.

Overview
Career Highlights

ORIC Pharmaceuticals, Inc.
Blueprint Medicines Corp.
Agensys, Inc.

RelSci Relationships

6368

Number of Boards

18

Birthday

1959

Age

62

Number of Awards

7

Relationships
RelSci Relationships are individuals Charles Sawyers likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Blueprint Medicines Corp.

Relationship likelihood: Strong

Co-Founder at Tango Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Member & Head, Program in Immunology, Clinical Research Division at Fred Hutchinson Cancer Research Center

Relationship likelihood: Strong

Venture Partner at ARCH Venture Partners

Relationship likelihood: Strong

President at Stanford University

Relationship likelihood: Strong

Charles A. Dana Chair in Human Cancer Genetics at Dana-Farber Cancer Institute, Inc.

Relationship likelihood: Strong

Science Partner at Nextech Invest AG

Relationship likelihood: Strong

Co-Founder at Revolution Medicines, Inc.

Relationship likelihood: Strong

Co-Founder at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paths to Charles Sawyers
Potential Connections via
Relationship Science
You
Charles Sawyers
Scientific Founder at Blueprint Medicines Corp.
Education
MD
Class of 1985

The Johns Hopkins University School of Medicine (JHUSOM), located in Baltimore, Maryland, U.S., is the academic medical teaching and research arm of Johns Hopkins University. Johns Hopkins has consistently been among the nation's top medical schools in the number of research grants awarded by the National Institutes of Health.

BA, History of Science

Princeton University is a vibrant community of scholarship and learning that stands in the nation's service and in the service of all nations. Chartered in 1746, Princeton is the fourth-oldest college in the United States. Princeton is an independent, coeducational, nondenominational institution that provides undergraduate and graduate instruction in the humanities, social sciences, natural sciences and engineering. As a world-renowned research university, Princeton seeks to achieve the highest levels of distinction in the discovery and transmission of knowledge and understanding. At the same time, Princeton is distinctive among research universities in its commitment to undergraduate teaching. Today, more than 1,100 faculty members instruct approximately 5,000 undergraduate students and 2,500 graduate students. The University's generous financial aid program ensures that talented students from all economic backgrounds can afford a Princeton education.

Memberships
Member
2010 - Current

The National Academy of Sciences (NAS) formed the Committee on International Security and Arms Control (CISAC) in 1980 as a permanent committee to bring the resources of the Academy to bear on critical problems of international security and arms control. CISAC, in the Policy and Global Affairs Division, draws from the nation’s finest scientific, technical, engineering and medical talent to advise the government, contribute to the work of non-governmental organizations, and inform the public about scientific and technical issues related to international security and arms control. CISAC’s work benefits from a rotating membership of distinguished scientists, policy and military experts. The Committee carries out its mandate through a variety of activities that receive financial support from public and private sponsors.

Member
Current

Founded in 1780, the American Academy of Arts and Sciences is an independent policy research center that conducts multidisciplinary studies of complex and emerging problems. The Academy’s elected members are leaders in the academic disciplines, the arts, business, and public affairs. With a current membership of 4,000 American Fellows and 600 Foreign Honorary Members, the Academy has four major goals: Promoting service and study through analysis of critical social and intellectual issues and the development of practical policy alternatives; Fostering public engagement and the exchange of ideas with meetings, conferences, and symposia bringing diverse perspectives to the examination of issues of common concern; Mentoring a new generation of scholars and thinkers through the Visiting Scholars Program and Hellman Fellowship Program; Honoring excellence by electing to membership men and women in a broad range of disciplines and professions. Click here to learn about our new members. The Academy's headquarters are in Cambridge, Massachusetts. With its geographically diverse membership, it conducts activities in this country and abroad

Member
Current

The National Academy of Medicine (NAM), formerly called the Institute of Medicine (IoM), is an American nonprofit, non-governmental organization. The National Academy of Medicine is a part of the National Academies of Sciences, Engineering, and Medicine, along with the National Academy of Sciences (NAS), National Academy of Engineering (NAE), and the National Research Council (NRC). The National Academy of Medicine provides national advice on issues relating to biomedical science, medicine, and health, and serves as an adviser to the nation to improve health. It aims to provide unbiased, evidence-based, and authoritative information and advice concerning health and science policy to policy-makers, professionals, leaders in every sector of society, and the public at large. Operating outside the framework of the U.S. federal government, it relies on a volunteer workforce of scientists and other experts, operating under a formal peer-review system. As a national academy, new members of the organization are elected annually by current members, based on their distinguished and continuing achievements in a relevant field as well as for their willingness to participate actively.

Career History
Co-Founder
2009 - Prior

Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA.

Investigator
2003 - Current

The Howard Hughes Medical Institute (HHMI) is a nonprofit medical research organization that ranks as one of the nation’s largest philanthropies. HHMI plays a prominent role in advancing biomedical research and science education in the United States. Founded in 1953 by aviator and industrialist Howard R. Hughes, HHMI is headquartered in Chevy Chase, Maryland, and employs more than 3,000 individuals across the U.S. HHMI has an endowment of $16.1 billion of which the Institute spent $800 million for research and distributed $119 million in grant support for science education in fiscal year 2012

Co-Founder
1997 - ?

Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA.

Boards & Committees
Member, Scientific Advisory Board
Current

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Member, Scientific Advisory Board
Current

BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Beijing, China.

Member, Scientific Advisory Board
Current

Blueprint Medicines Corp. is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.

President, Board of Directors
Current

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

Member Emeritus, Board of Trustees
Current

ACCELERATES THE CONQUEST OF CANCER BY FUNDING SCIENTIFIC RESEARCH, EDUCATION AND COMMUNICATION.

Vice Chairman, Board of Trustees
Prior - 2020

Cold Spring Harbor Laboratory, Inc. provides research services. It operates educational institutions. The firm offers research in cancer, neurobiology, plant genetics, and bioinformatics. It also offers laboratory workshops to science teachers, students, and other groups across the nation. The company was founded in 1890 and is headquartered in Cold Spring Harbor, NY.

Member, Board of Scientific Councilors
Prior

The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical practice.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$10K - $25K
2017

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

$10K - $25K
2016

ACCELERATES THE CONQUEST OF CANCER BY FUNDING SCIENTIFIC RESEARCH, EDUCATION AND COMMUNICATION.

$10K - $25K
2016

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

Political Donations
$250
2008

Former President of United States

Investments
Details Hidden

Oric Pharmaceuticals, Inc. is a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.

Details Hidden

Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
2013
Breakthrough Prize in Life Sciences
2009
Lasker-DeBakey Clinical Medical Research Award
American Association of Cancer Research - Richard and Hinda Rosenthal Memorial Award
Events
Speaker
Davos, Switzerland
2008 World Economic Forum Annual Meeting

The World Economic Forum Annual Meeting 2008 convened in Davos at a time of great anxiety in the world. The turmoil in the financial markets and the continuing conflict in the Middle East were naturally of immediate concern. Mounting awareness of the epochal challenge of climate change and the looming threat of global terrorism, two issues that were addressed in the opening plenary session, heightened our shared sense of urgency. The Annual Meeting theme - The Power of Collaborative Innovation - was a fitting focus for two reasons. First, it highlighted that a multistakeholder approach is critical for any authentic and viable solutions to global problems. And second, it served to underline the need for new and imaginative ways to mitigate global risks and the importance of achieving tangible results or value.

Speaker
Los Angeles, CA, United States
2004 Milken Institute Global Conference

Through a unique international agenda and some of the smartest speakers on the planet, the Milken Institute Global Conference tackles the world’s most difficult challenges in an array of fields - from finance and philanthropy, to the environment and education, to government and health.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Charles Sawyers. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Charles Sawyers's profile does not indicate a business or promotional relationship of any kind between RelSci and Charles Sawyers.